Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revlimid Consolidation in CLL
NCT01600053Phase 2Terminated
- Start
- Nov 2011
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in chronic lymphocytic leukemia (CLL). Started Nov 2011; status: terminated.
02
Drugs
lenalidomide
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01600053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01600053.